Publications
813
Citations
40,928
Est. group size
—
Recurring co-author estimate
Active years
54
Publishing since 1973
Lawrence H. Einhorn conducts clinical cancer research (medical oncology), with a strong focus on testicular germ cell tumors, including how they are treated, how patients fare long-term, and the genetics behind them. His work also covers lung cancer therapies, chemotherapy side effects such as nerve damage from cisplatin, and treatments for cancers that stop responding to standard drugs. Much of the research involves clinical trials testing drug regimens and reviewing best practices in cancer management.
Publication activity has remained steady over the decade, averaging about 22 papers per year over the last five years with year-to-year fluctuation.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Key Updates in Testicular Cancer: Optimizing Survivorship and Survival
American Society of Clinical Oncology Educational Book · 2025
- <i>ALK</i> -Rearranged Non–Small Cell Lung Cancer Presenting as a Large Mediastinal Mass: A Case Report
JCO Precision Oncology · 2025
- Love in the Time of Cancer
2024
- Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes
European Urology · 2023
- Controvérsias no Tratamento dos Estádios I e II dos Tumores de Células Germinativas Não-Seminomatosos do Testículo
Revista Brasileira de Cancerologia · 2023
- Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)
Supportive Care in Cancer · 2021
- Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153
Journal of Clinical Oncology · 2020
- Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)
Supportive Care in Cancer · 2020
- Controversies in the management of clinical stage 1 testis cancer
Canadian Urological Association Journal · 2020
- Clinical dilemmas in local and regional testis cancer
Canadian Urological Association Journal · 2020
- A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors
PMC · 2019
- Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153)
Journal of Thoracic Oncology · 2019
- A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors
Investigational New Drugs · 2019
- A Canadian approach to the regionalization of testis cancer: A review
Canadian Urological Association Journal · 2019
- Clinical course of patients with cisplatin (CDDP)-associated neuropathy compared to other neurotoxic chemotherapy.
Journal of Clinical Oncology · 2019
- Journal of Clinical Oncology×103
- The Journal of Urology×11
- Clinical Genitourinary Cancer×7
- Annals of Oncology×6
- Cancer Research×6
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile